SEARCH

SEARCH BY CITATION

References

  • Aiassa V, Barnes AI & Albesa I (2007) Action of ciprofloxacin on planktonic bacteria and biofilm of Proteus mirabilis. Biofilms 3: 1117.
  • Aiassa V, Barnes AI & Albesa I (2010) Resistance to ciprofloxacin by enhancement of antioxidant defenses in biofilm and planktonic Proteus mirabilis. Biochem Biophys Res Commun 393: 8488.
  • Albesa I, Becerra MC, Battán PC & Páez PL (2004) Oxidative stress involved in the antibacterial action of different antibiotics. Biochem Biophys Res Commun 317: 605609.
  • Becerra MC & Albesa I (2002) Oxidative stress induced by ciprofloxacin in Staphylococcus aureus. Biochem Biophys Res Commun 297: 10031007.
  • Benzie IF & Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 239: 7076.
  • Benzie IF & Strain JJ (1999) Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 299: 1527.
  • Chen PR, Brugarolas P & He C (2011) Redox signaling in human pathogens. Antioxid Redox Signal 14: 11071118.
  • Di Bernardini R, Rai DK, Bolton D, Kerry J, O'Neill E, Mullen AM, Harnedy P & Hayes M (2011) Isolation, purification and characterization of antioxidant peptidic fractions from a bovine liver sarcoplasmic protein thermolysin hydrolyzate. Peptides 32: 388400.
  • Dwyer DJ, Kohanski MA & Collins JJ (2009) Role of reactive oxygen species in antibiotic action and resistance. Curr Opin Microbiol 12: 482489.
  • Giraud E, Brisabois A, Martel JL & Chaslus-Dancla E (1999) Comparative studies of mutations in animal isolates and experimental in-vitro and in-vivo mutants of Salmonella spp. suggest a counter selection of highly fluoroquinolone-resistant strains in the field. Antimicrob Agents Chemother 43: 21312137.
  • Goswami M, Mangoli SH & Jawali N (2006) Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli. Antimicrob Agents Chemother 50: 949954.
  • Huang D, Ou B & Prior RL (2005) The chemistry behind antioxidant capacity assays. J Agric Food Chem 23: 18411856.
  • Kern WV, Oethinger M, Jellen-Ritter AS & Levy SB (2000) Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother 44: 814820.
  • Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA & Collins JJ (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130: 797810.
  • Kohanski MA, De Pristo MA & Collins JJ (2010) Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell 37: 311320.
  • Koziol S, Zagulski M, Bilinski T & Bartosz G (2005) Antioxidants protect the yeast Saccharomyces cerevisiae against hypertonic stress. Free Radic Res 39: 365371.
  • Krisko A & Radman M (2010) Protein damage and death by radiation in Escherichia coli and Deinococcus radiodurans. P Natl Acad Sci USA 107: 1437314377.
  • Litescu SC, Eremia S & Radu GL (2011) Methods for the determination of antioxidant capacity in food and raw materials. Adv Exp Med Biol 698: 241249.
  • Magalhães LM, Segundo MA, Reis S & Lima JL (2008) Methodological aspects about in vitro evaluation of antioxidant properties. Anal Chim Acta 613: 119.
  • Maneewannakul K & Levy SB (1996) Identification of mar mutants among quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother 40: 16951698.
  • Miller P & Sulavik MC (1996) Overlaps and parallels in the regulation of intrinsic multiple-antibiotic resistance in Escherichia coli. Mol Microbiol 21: 441448.
  • Nilsson J, Pillai D, Onning G, Persson C, Nilsson A & Akesson B (2005) Comparison of the 2,2′-azinobis-3-ethylbenzotiazo-line-6-sulfonic acid (ABTS) and ferric reducing anti-oxidant power (FRAP) methods to assess the total antioxidant capacity in extracts of fruit and vegetables. Mol Nutr Food Res 49: 239246.
  • Oethinger M, Podglajen I, Kern WV & Levy SB (1998) Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrob Agents Chemother 42: 20892094.
  • Páez PL, Becerra MC & Albesa I (2010) Effect of the association of reduced glutathione and ciprofloxacin on the antimicrobial activity in Staphylococcus aureus. FEMS Microbiol Lett 303: 101105.
  • Piddock L (1999) Mechanisms of fluoroquinolone resistance: an update 1994–1998. Drugs 58: 18.
  • Piechota A & Goraca A (2009) [The comparison of alpha-lipoic acid, melatonin, vitamin C and trolox effectiveness in decreasing DNA stand brakes and increasing plasma antioxidant power]. Pol Merkur Lekarski 27: 1921.
  • Ruiz J (2003) Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 51: 11091117.
  • Saito R, Sato K, Kumita W, Inami N, Nishiyama H, Okamura N, Moriya1 K & Koike K (2006) Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis. J Antimicrob Chemother 58: 673677.
  • Schlesier K, Harwat M, Böhm V & Bitsch R (2002) Assessment of antioxidant activity by using different in vitro methods. Free Radic Res 36: 177187.
  • Stauffer CE (1975) A linear standard curve for the Folin Lowry determination of protein. Anal Biochem 69: 646648.
  • Tattevin P, Basuino L & Chambers HF (2009) Subinhibitory fluoroquinolone exposure selects for reduced beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus and alterations in the SOS-mediated response. Res Microbiol 160: 187192.
  • Thaipong K, Boonprakob U, Crosby K, Cisneros-Zevallos L & Byrne DH (2006) Comparison of ABTS, DPPH, FRAP, and ORAC assays for estimating antioxidant activity from guava fruit extracts. J Food Compost Anal 19: 669675.
  • Weigel LM, Anderson GJ & Tenover FC (2002) DNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilis. Antimicrob Agents Chemother 46: 25822587.
  • Wick LM & Egli T (2004) Molecular components of physiological stress responses in Escherichia coli. Adv Biochem Eng Biotechnol 89: 145.
  • Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillère-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drüeke T & Descamps-Latscha B (1998) Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161: 25242532.